Efficacy of ibrutinib as salvage treatment in a secondary central nervous system lymphoma (SCNSL) progressed after chemorefractory Primary Mediastinal B Cell Lymphoma (PMBCL)

Leuk Lymphoma. 2022 Feb;63(2):483-486. doi: 10.1080/10428194.2021.1978091. Epub 2021 Oct 6.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adenine / analogs & derivatives
  • Central Nervous System / pathology
  • Central Nervous System Neoplasms* / diagnosis
  • Central Nervous System Neoplasms* / drug therapy
  • Humans
  • Lymphoma*
  • Lymphoma, B-Cell* / pathology
  • Lymphoma, Large B-Cell, Diffuse* / diagnosis
  • Lymphoma, Large B-Cell, Diffuse* / drug therapy
  • Lymphoma, Large B-Cell, Diffuse* / pathology
  • Mediastinal Neoplasms* / pathology
  • Piperidines
  • Salvage Therapy

Substances

  • Piperidines
  • ibrutinib
  • Adenine